These studies suggest that ApoEε4 may play a role in tau pathology, which would be critical as findings from clinical PET, CSF, and post-mortem studies suggest that the pathological aggregation of tau is closely linked to patterns of neurodegeneration and cognitive deficits in AD37–39. The gene discussed is MAPT; the disease is Cognitive impairment.